The use of MRI, FDG‐PET and CSF biomarkers in young‐onset cognitive disorders: real‐world clinical evidence on the concordance of investigations
Molly J Whitmore, Christopher G S Gilmartin, Christopher Tench, Elizabeta Mukaetova‐Ladinska, Akram A Hosseini · 2025
Read The use of MRI, FDG‐PET and CSF biomarkers in young‐onset cognitive disorders: real‐world clinical evidence on the concordance of investigations by Molly J Whitmore, Christopher G S Gilmartin, Christopher Tench, Elizabeta Mukaetova‐Ladinska, Akram A Hosseini (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716704.txt.
Description
Molly J Whitmore and four co-authors published a study in 2025 on how well common tests agree in young people with thinking problems. Doctors use MRI scans, a type of PET scan, and spinal fluid tests to find the cause. These tests do not always point the same way, and the study checked them against the final diagnosis in real clinic practice.
The team followed patients at a referral clinic in England, including 265 people aged forty to seventy. Early results showed poor agreement between the two scan types. Spinal fluid tests matched an Alzheimer's diagnosis only part of the time, so the authors urge judging all evidence together. The study is a useful check on how test results should be weighed in practice.
Catalog record
| CREATOR | Molly J Whitmore, Christopher G S Gilmartin, Christopher Tench, Elizabeta Mukaetova‐Ladinska, Akram A Hosseini |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |